Resolve Digital Health Goes Global
May 9th, 2019
TORONTO, May 9, 2019 /PRNewswire/ — Resolve Digital Health (“Resolve” or the “Company”), a Canadian developer of intelligent cannabis solutions and innovative technologies, today announced that the Company will seek Health Canada approval as a Medical Device License for two more of its smart vaporizers for use with cannabis.
Following the recent successful license approval by Health Canada of the Resolve MD as a medical device, the Resolve Mini MD and the Resolve Go MD will also be submitted for Medical Device License approval. The Resolve Mini MD is a dried cannabis vaporizer featuring the same technology as the Resolve MD in a smaller form factor and without a touchscreen. The Resolve Go MD is an oil vaporizer and, if approved, would become the first cannabis oil vaporizer to be granted a Medical Device License by Health Canada. Initially, the Resolve Go MD will focus on the CBD oil medical cannabis market, and then expand as increased legalization provides more options to patients.
“Resolve’s mission is to serve patients,” says Rob Adelson, CEO of Resolve. “That means everything we innovate must first meet patient needs, be safe and exceed all regulatory requirements. It doesn’t hurt that our devices are uniquely different and extremely cool, too.”
All of Resolve’s medical cannabis vaporizers assist the patient in taking control of their healthcare, utilizing technology that ensures consistent dosing and a professional experience. Further, to make usage as easy as possible for the patient, the Company is partnering with licensed producers to fill proprietary pods and cartridges with pre-selected cannabis formulations that are then simply inserted into the device. Beyond devices, Resolve develops apps that assist patients in capturing data on medical conditions, prescriptions, family history, lifestyle, and effectiveness per dose, then utilizes those data points to improve the medical cannabis treatment experience for patients and caregivers.
Beyond making further applications to Health Canada, the Company has its sights set on the global market and to this end is working towards:
- certification for its medical devices in the EU, with plans on launching in Germany in 2020;
- meeting the requirements in countries such as Germany and the United Kingdom for Resolve’s ecosystem to be fully reimbursable to patients;
- medical devices approval and registration by the Therapeutic Goods Administration in Australia with a launch planned for 2020;
- satisfying regulatory requirements in Israel; and
- obtaining regulatory approval for its devices in Central and South America, particularly Mexico and Brazil.
“There are massive markets forming all over the world,” Adelson explains. ” For example, Europe is expected to be the world’s largest legal cannabis market with a population of more than double that of the United States and Canada combined, estimated to be €123 billion by 2028.* This market is going to be heavily focussed on medical patients, data and dosing technology. Resolve intends to be a leader in this market with approved medical device technology, medical formulations and reimbursement programs in several countries.”
For more information, please visit www.resolvedigitalhealth.com
*The European Cannabis Report, 4th Edition. Prohibition Partners. January 2019
About Resolve Digital Health
Resolve Digital is positioned to be the leading provider of cannabis-related business solutions and technologies for the health and wellness markets. The Company’s cloud-based health information platform, apps and family of innovative devices with metered dosing address the numerous issues with currently available methods of cannabis delivery – establishing a data-driven standard of care for the cannabis industry. After three years of research and development, the Company’s first products will soon be available in Canada.
SOURCE Resolve Digital Health
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.